6:50am ET
Investing
Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
JNJ Coverage Page 48
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More
Friday's top analyst upgrades, downgrades and initiations included Apple, Canopy Growth, CrowdStrike, Delta Air Lines, Johnson & Johnson, Rio Tinto, Roku, Square, Tilray and Twilio.
12:25pm ET
Health and Healthcare
Johnson & Johnson Has a Lot on Its Hands After $8 Billion Court Ruling
Johnson & Johnson shares dropped on Wednesday following the announcement that a jury has awarded $8 billion in damages to a man accusing the drugmaker of failing to warn about the side…
Chris Lange 10:50am ET
Health and Healthcare
Johnson & Johnson May Have Just Dodged a Big Opioid Bullet
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
Chris Lange 12:00pm ET
Health and Healthcare
Unusual Settlement Deal Proposed for Opioid Lawsuits
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the hundreds…
7:30am ET
Investing
5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners
The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid long-term prospects.
7:11am ET
Investing
As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus
As, when and if ESG themes continue to gain in popularity, imagine what could happen to some of the top-ranked ESG companies. Imagine also what could happen to some of the companies…
11:25am ET
Health and Healthcare
Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
12:10pm ET
Health and Healthcare
Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
7:20am ET
Health and Healthcare
5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense
Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to blame. Some rivals may have been winning at the company's expense.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray and VMware.
3:29pm ET
Health and Healthcare
Why Johnson & Johnson Shareholders May Have to Ignore Earnings Looking Ahead
Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings that shareholders are having a hard time quantifying.
Jon C. Ogg 10:20am ET
Health and Healthcare
Johnson & Johnson Slides By With Q2 Earnings
Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Chris Lange 12:55pm ET
Health and Healthcare
What to Watch When Johnson & Johnson Reports Tomorrow
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
Chris Lange 10:20am ET
Investing
Microsoft, Netflix, eBay, Johnson & Johnson and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of Johnson & Johnson, Microsoft, Netflix and the other most prominent of the many earnings reports that are expected this week.